Searching for New Cures for Tuberculosis: Design, Synthesis, and Biological Evaluation of 2-Methylbenzothiazoles

作者: Qingqing Huang , Jialin Mao , Baojie Wan , Yuehong Wang , Reto Brun

DOI: 10.1021/JM901112F

关键词:

摘要: The actual development and clinical use of new therapeutics for tuberculosis (TB) have remained stagnant years because the complexity disease process, treatment which at present requires administration drug combinations over a 6 month period. There is thus an urgent need discovery novel, more active, less toxic anti-TB agents. In this study, we report on chemistry biology series potent 5-(2-methylbenzothiazol-5-yloxymethyl)isoxazole-3-carboxamide derivatives, proved to be active against replicating Mycobacterium (Mtb) H37Rv. most compounds 7j 7s were found inhibit Mtb growth micromolar concentrations, with MIC values 1.4 1.9 μM, respectively. Impressively, all nontoxic toward Vero cells (IC50 > 128 μM). Moreover, best these also tested protozoan parasites, some show activity, especially Pla...

参考文章(14)
R. G. MICETICH, C. C. SHAW, T. W. HALL, P. SPEVAK, R. A. FORTIER, P. WOLFERT, B. C. FOSTER, B. K. BAINS, THE 5-ALKOXYMETHYL-, 5-ALKYLTHIOMETHYL-, AND 5-DIALKYLAMINOMETHYLISOXAZOLES Heterocycles. ,vol. 23, pp. 571- 583 ,(1985) , 10.1002/CHIN.198530214
Eiji Kashiyama, Ian Hutchinson, Mei-Sze Chua, Sherman F. Stinson, Lawrence R. Phillips, Gurmeet Kaur, Edward A. Sausville, Tracey D. Bradshaw, Andrew D. Westwell, Malcolm F. G. Stevens, Antitumor benzothiazoles. 8. Synthesis, metabolic formation, and biological properties of the C- and N-oxidation products of antitumor 2-(4-aminophenyl)benzothiazoles. Journal of Medicinal Chemistry. ,vol. 42, pp. 4172- 4184 ,(1999) , 10.1021/JM990104O
Annamaria Lilienkampf, Jialin Mao, Baojie Wan, Yuehong Wang, Scott G. Franzblau, Alan P. Kozikowski, Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis. Journal of Medicinal Chemistry. ,vol. 52, pp. 2109- 2118 ,(2009) , 10.1021/JM900003C
Graham S. Timmins, Vojo Deretic, Mechanisms of action of isoniazid Molecular Microbiology. ,vol. 62, pp. 1220- 1227 ,(2006) , 10.1111/J.1365-2958.2006.05467.X
Meiji Arai, Yasmene I.H. Alavi, Jacqueline Mendoza, Oliver Billker, Robert E. Sinden, Isonicotinic acid hydrazide: an anti-tuberculosis drug inhibits malarial transmission in the mosquito gut. Experimental Parasitology. ,vol. 106, pp. 30- 36 ,(2004) , 10.1016/J.EXPPARA.2004.01.002
S. Ganapaty, P. Steve Thomas, Gloria Karagianis, Peter G. Waterman, Reto Brun, Antiprotozoal and cytotoxic naphthalene derivatives from Diospyros assimilis Phytochemistry. ,vol. 67, pp. 1950- 1956 ,(2006) , 10.1016/J.PHYTOCHEM.2006.05.039
Chester A. Mathis, Yanming Wang, Daniel P. Holt, Guo-Feng Huang, Manik L. Debnath, William E. Klunk, Synthesis and Evaluation of11C-Labeled 6-Substituted 2-Arylbenzothiazoles as Amyloid Imaging Agents Journal of Medicinal Chemistry. ,vol. 46, pp. 2740- 2754 ,(2003) , 10.1021/JM030026B
Yoonsang Cho, Thomas R. Ioerger, James C. Sacchettini, Discovery of novel nitrobenzothiazole inhibitors for Mycobacterium tuberculosis ATP phosphoribosyl transferase (HisG) through virtual screening. Journal of Medicinal Chemistry. ,vol. 51, pp. 5984- 5992 ,(2008) , 10.1021/JM800328V
Kanakeshwari Falzari, Zhaohai Zhu, Dahua Pan, Huiwen Liu, Poonpilas Hongmanee, Scott G. Franzblau, In Vitro and In Vivo Activities of Macrolide Derivatives against Mycobacterium tuberculosis Antimicrobial Agents and Chemotherapy. ,vol. 49, pp. 1447- 1454 ,(2005) , 10.1128/AAC.49.4.1447-1454.2005